Cello World Limited has announced its quarterly earnings conference call to discuss the unaudited financial results for the third quarter of fiscal year 2026. The company informed stock exchanges on February 11, 2026, about the scheduled call pursuant to Regulation 30 of the Listing Regulations.

Conference Call Details

The earnings call is scheduled for Monday, February 16, 2026 at 09:00 AM Indian Standard Time. The session will focus on discussing the company's financial performance for the quarter ended December 31, 2025.

Management Participation

The conference call will be represented by key members of Cello World's senior management team:

• Mr. Gaurav Rathod - Joint Managing Director
• Mr. Atul Parolia - Chief Financial Officer

Access Information

ICICI Securities is facilitating the conference call and has provided multiple access options for participants. The universal access numbers include +91 22 6280 1144 and +91 22 7115 8045 for domestic participants.

International Toll-Free Numbers

Additional Information

The company has indicated that a transcript of the earnings conference call will be made available on Cello World's official website following the session. This ensures broader accessibility for stakeholders who may not be able to participate in the live call.

The announcement was signed by Hemangi Trivedi, Company Secretary and Compliance Officer, on behalf of Cello World Limited. ICICI Securities team members including Mr. Jaideep Goswami, Head of Equities, and Mr. Manoj Menon, Head of Research, are coordinating the call arrangements.

Cello World Limited has secured regulatory approval to expand its employee stock option program, receiving in-principle clearance from India's major stock exchanges for listing additional equity shares under its employee benefits scheme.

Exchange Approvals Received

The company announced that both the National Stock Exchange of India Limited and BSE Limited have granted in-principle approval for listing equity shares under the CELLO ESOP-2025 scheme. The approvals were issued on January 05, 2026, marking a significant milestone for the company's employee incentive program.

ESOP Scheme Details

The approval covers the listing of up to a maximum of 66,26,551 equity shares with a face value of ₹5.00 each. These shares will be issued to employees of Cello World Limited upon exercise of stock options granted under the CELLO ESOP-2025 scheme.

Regulatory Compliance Requirements

Both exchanges have outlined specific conditions that must be fulfilled before the final listing approval. The key requirements include:

• Notification to exchanges under Regulation 10(c) after allotment of securities
• Receipt of all statutory and regulatory approvals from SEBI, RBI, and MCA
• Compliance with SEBI (LODR) Regulations, 2015
• Adherence to Companies Act provisions and other applicable laws
• Submission of required documentation including board resolutions and allottee details

Documentation and Next Steps

The exchanges have specified that Cello World Limited must submit certified copies of various documents, including the statement under Regulation 10(c), board resolution of allotment, and detailed lists of allottees. The company must also provide confirmation from registrar and transfer agents regarding credit to beneficiary accounts or dispatch of physical certificates.

Both NSE and BSE have reserved the right to withdraw their in-principle approval if any information submitted is found to be incomplete, incorrect, or misleading. The final trading permission will be granted upon receipt of proper notification and compliance with all stated conditions.

The approval enables Cello World Limited to proceed with its employee stock option scheme, providing a mechanism to incentivize and retain talent through equity participation in the company's growth.